Non-invasive determination of glucose concentration in body of patients

• US 5,070,874 A
• Filed: 01/30/1990
• Issued: 12/10/1991
• Est. Priority Date: 01/30/1990
• Status: Expired due to Term

• Current Assignee: Dominion Assets LLC
• Original Assignee: Biocontrol Technology Inc. (Touchpoint Group Holdings, Inc.)
• Inventors: Barnes, Russell H., Purdy, David L., Brasch, Jimmie W. Sr.
• Primary Examiner(s): Jaworski, Francis
• Assistant Examiner(s): Akers, Scoh R.
• Application Number:
  US07/482,792
• Time in Patent Office: 679 Days
• Field of Search: 128/634, 128/633, 128/664, 128/665, 356/39, 356/40, 356/41
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01J 3/433 Modulation spectrometry; Derivative spectrometry

Abstract

Radiation in the near infrared over a limited range of wavelengths about 1660 nanometers is projected on a portion of the body, for example, the ear, of the patient. The resulting radiation emitted by the portion, either scattered from the portion or transmitted after absorption and scattered by the portion, is processed to derive an expression of the resulting radiation as a function of the wavelength. The second derivative of this function over a very narrow range of this function between 1640 and 1670 nanometers is expanded and the glucose concentration is determined from the magnitude, or intensity, of the scattered or transmitted radiation at the maximum or minimum point of this derivative apparatus for non-invasive determination of glucose concentration in the patient. Radiation in the near infrared is transmitted through a first fiber-optic radiation conductor to the outer surface of a portion of the patient'"'"'s body, penetrating into the portion. A second fiber-optic conductor transmits the resulting radiation emitted from the portion to data processing means which produces the desired second derivative as a function of the wavelength of the incident radiation. The processor includes a spectrum analyzer which produces a spectrum of the resulting radiation.

Claims

1. The method of non-invasive determination of the concentration of glucose in a patient with apparatus including a source of radiation of wavelengths in the near infrared;

the said method comprising;

projecting radiation from said source on a portion of the body of said patient, varying the wavelengths of the radiation projected on said portion of said body over a limited range of wavelengths in the near infrared, sensing the resulting radiation emitted from said portion of said body, deriving from said sensed resulting radiation a first expression for the magnitude of said sensed radiation as a function of the wavelength to locate a region of said expression where the expression shows maximum influence by the portion of said body on the resulting radiation, responsive to the content of glucose in said patient of the portion of said body on the radiation incident on said portion of said body, deriving a second expression for the nth derivative of said function with respect to wavelength about a narrow range of wavelengths of the radiation of said region, producing an enlargement of said second expression over said narrow range of wavelengths, and determining said concentration of said glucose from the magnitude at a selected point of said enlargement of said second expression.

4. The method of claim 1 wherein the narrow range is between about 1640 and 1670 nanometers.

8. The method of claim 1 wherein the nth derivative is the second derivative.

2. The method of non-invasive determination of the concentration of the glucose in a patient with apparatus including a source of radiation of wavelengths in the near infrared;

said method comprising;

projecting radiation of wavelengths in the near infrared on a portion of the body of said patient, varying the wavelength of said projected radiation over a narrow range of wavelengths about the wavelength of approximately 1660 nanometers, sensing the resulting radiation emitted from said portion of said body, deriving an expression for the magnitude of the resulting radiation as a function of the wavelength of said radiation, and determining said magnitude of the glucose by evaluating the nth derivative of said expression in an enlarged narrow range at about 1660 nanometers to determine the magnitude of the resulting radiation at the wavelength about 1660 nanometers at which the influence of said portion of said body on the radiation from said source incident thereon is a maximum, thereby to determine the concentration of the glucose in said patient.

6. The method of claim 2 wherein the narrow range is between about 1640 nanometers and 1670 nanometers.

3. The method of non-invasive determination of the concentration of the glucose in a patient with apparatus including a source of radiation of wavelengths in the near infrared;

the said method comprising;

projecting from said source radiation of wavelength in the near infrared on a portion of the body of said patient, varying the wavelength of the radiation projected on said portion of said body over a limited range of wavelengths in the near infrared about the wavelength of approximately 1660 nanometers, sensing the resulting radiation emitted by said portion of said body to derive an expression which is a measure of the magnitude of said resulting radiation as a function of the wavelength of the impinging radiation having a stationary point in the region of 1660 nanometers, deriving the nth order derivative of said expression over a narrow range of wavelengths immediately in the region of 1660 nanometers, and determining the concentration of the glucose from said stationary point of said nth order derivative.

5. The method of claim 3 wherein the limited range is between about 1100 and 1900 nanometers and the narrow range is between about 1640 and 1670 nanometers.

7. The method of claim 3 wherein the nth derivative is the second derivative.

9. Apparatus for non-invasive determination of the concentration of glucose in a patient including:

a source of infrared radiation, a first fiber-optic conductor of radiation adapted to be connected to an external surface of a portion of the body of said patient, means positioning said first fiber-optic conductor to transmit radiation from said source to said portion through said surface as incident radiation thereon, a second fiber-optic conductor of radiation adapted to be connected to an external surface of said portion of the body of the patient to transmit radiation emitted from said portion resulting from the impingement of said incident radiation, first deriving means, connected to said second fiber-optic conductor, to derive from said resulting radiation a first continuous expression defining the magnitude of said resulting radiation as a function of wavelength of said radiation and a second deriving means, connected to said first deriving means, for deriving from the first expression a second expression defining the nth derivative of the first expression as a function of wavelength of the radiation, and means, connected to said second deriving means, for processing the resulting radiation from said portion in dependence upon said continuous expression to determine said concentration.

10. The apparatus of claim 9 wherein the deriving means includes means for scanning the resulting radiation continuously over a predetermined range of wavelengths and means, responsive to said scanning means, to derive the expression.

11. The apparatus of claim 9 wherein the deriving means includes a spectrum analyzer for analyzing the spectrum of the resulting radiation emitted by the portion of the body of the patient and also includes means, connected to said analyzer, for deriving the expression for said resulting radiation as a function of the wavelength.

12. The apparatus of claim 9, the processing means includes second deriving means, connecting wherein processing means is controlled by the second expression to determine the concentration.

13. The method of non-invasive determination of the concentration of glucose in a patient with apparatus including a source of radiation of wavelengths in the near infrared;

the said method comprising;

projecting radiation from said source on a portion of the body of said patient, varying the wavelengths of the radiation projected on said portion of said body over a limited range of wavelengths in the near infrared, sensing the resulting radiation emitted from said portion of said body, deriving from said sensed resulting radiation a first expression for the magnitude of said sensed radiation as a function of the wavelength to locate a region of said first expression where said expression shows maximum influence by the portion of said body on the resulting radiation responsive to the content of glucose in said patient on the radiation incident on said portion of said body, deriving a second expression for the nth derivative of said expression with respect to wavelength about a narrow range of wavelengths of said region, and determining said concentration of said glucose from the magnitude of said second expression at a selected point of said narrow range.